1226 related articles for article (PubMed ID: 19801106)
1. Proton beam radiotherapy versus three-dimensional conformal stereotactic body radiotherapy in primary peripheral, early-stage non-small-cell lung carcinoma: a comparative dosimetric analysis.
Macdonald OK; Kruse JJ; Miller JM; Garces YI; Brown PD; Miller RC; Foote RL
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):950-8. PubMed ID: 19801106
[TBL] [Abstract][Full Text] [Related]
2. Can protons improve SBRT for lung lesions? Dosimetric considerations.
Georg D; Hillbrand M; Stock M; Dieckmann K; Pötter R
Radiother Oncol; 2008 Sep; 88(3):368-75. PubMed ID: 18405986
[TBL] [Abstract][Full Text] [Related]
3. Dose-volume comparison of proton radiotherapy and stereotactic body radiotherapy for non-small-cell lung cancer.
Kadoya N; Obata Y; Kato T; Kagiya M; Nakamura T; Tomoda T; Takada A; Takayama K; Fuwa N
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1225-31. PubMed ID: 20732759
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
[TBL] [Abstract][Full Text] [Related]
5. Impact of IMRT and leaf width on stereotactic body radiotherapy of liver and lung lesions.
Dvorak P; Georg D; Bogner J; Kroupa B; Dieckmann K; Pötter R
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1572-81. PubMed ID: 15817364
[TBL] [Abstract][Full Text] [Related]
6. Double-scattered proton-based stereotactic body radiotherapy for stage I lung cancer: a dosimetric comparison with photon-based stereotactic body radiotherapy.
Hoppe BS; Huh S; Flampouri S; Nichols RC; Oliver KR; Morris CG; Mendenhall NP; Li Z
Radiother Oncol; 2010 Dec; 97(3):425-30. PubMed ID: 20934768
[TBL] [Abstract][Full Text] [Related]
7. Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non-small-cell lung cancer.
Schwarz M; Alber M; Lebesque JV; Mijnheer BJ; Damen EM
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):561-70. PubMed ID: 15890601
[TBL] [Abstract][Full Text] [Related]
8. Feasibility report of image guided stereotactic body radiotherapy (IG-SBRT) with tomotherapy for early stage medically inoperable lung cancer using extreme hypofractionation.
Hodge W; Tomé WA; Jaradat HA; Orton NP; Khuntia D; Traynor A; Weigel T; Mehta MP
Acta Oncol; 2006; 45(7):890-6. PubMed ID: 16982555
[TBL] [Abstract][Full Text] [Related]
9. Once-weekly, high-dose stereotactic body radiotherapy for lung cancer: 6-year analysis of 60 early-stage, 42 locally advanced, and 7 metastatic lung cancers.
Salazar OM; Sandhu TS; Lattin PB; Chang JH; Lee CK; Groshko GA; Lattin CJ
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):707-15. PubMed ID: 18455322
[TBL] [Abstract][Full Text] [Related]
10. Benefit of respiration-gated stereotactic radiotherapy for stage I lung cancer: an analysis of 4DCT datasets.
Underberg RW; Lagerwaard FJ; Slotman BJ; Cuijpers JP; Senan S
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):554-60. PubMed ID: 15890600
[TBL] [Abstract][Full Text] [Related]
11. Comparative treatment planning on localized prostate carcinoma conformal photon- versus proton-based radiotherapy.
Mock U; Bogner J; Georg D; Auberger T; Pötter R
Strahlenther Onkol; 2005 Jul; 181(7):448-55. PubMed ID: 15995838
[TBL] [Abstract][Full Text] [Related]
12. Dummy run for a phase II study of stereotactic body radiotherapy of T1-T2 N0M0 medical inoperable non-small cell lung cancer.
Djärv E; Nyman J; Baumann P; Ekberg L; Høyer M; Lax I; Lewensohn R; Levin N; Lund JA; Morhed E; Ericsson SR; Traberg A; Wittgren L; Johansson KA
Acta Oncol; 2006; 45(7):973-7. PubMed ID: 16982566
[TBL] [Abstract][Full Text] [Related]
13. Dose coverage beyond the gross tumor volume for various stereotactic body radiotherapy planning techniques reporting similar control rates for stage I non-small-cell lung cancer.
Arvidson NB; Mehta MP; Tomé WA
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1597-603. PubMed ID: 19028283
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric comparison of two arc-based stereotactic body radiotherapy techniques for early-stage lung cancer.
Liu H; Ye J; Kim JJ; Deng J; Kaur MS; Chen ZJ
Med Dosim; 2015; 40(1):76-81. PubMed ID: 25499078
[TBL] [Abstract][Full Text] [Related]
15. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer.
Chang JY; Zhang X; Wang X; Kang Y; Riley B; Bilton S; Mohan R; Komaki R; Cox JD
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1087-96. PubMed ID: 16682145
[TBL] [Abstract][Full Text] [Related]
16. [Outcome of three-dimensional conformal radiotherapy for early stage non-small cell lung cancer patients who met or not inclusion criteria for stereotactic-body radiation therapy].
Kołodziejczyk M; Kępka L; Tyc-Szczepaniak D; Wierzchowski M
Pneumonol Alergol Pol; 2011; 79(5):326-36. PubMed ID: 21861256
[TBL] [Abstract][Full Text] [Related]
17. Dose distribution analysis in stereotactic body radiotherapy using dynamic conformal multiple arc therapy.
Takeda A; Kunieda E; Sanuki N; Ohashi T; Oku Y; Sudo Y; Iwashita H; Ooka Y; Aoki Y; Shigematsu N; Kubo A
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):363-9. PubMed ID: 19427552
[TBL] [Abstract][Full Text] [Related]
18. Influence of calculation algorithm on dose distribution in irradiation of non-small cell lung cancer (NSCLC) collapsed cone versus pencil beam.
Koelbl O; Krieger T; Haedinger U; Sauer O; Flentje M
Strahlenther Onkol; 2004 Dec; 180(12):783-8. PubMed ID: 15592698
[TBL] [Abstract][Full Text] [Related]
19. Proton radiation therapy offers reduced normal lung and bone marrow exposure for patients receiving dose-escalated radiation therapy for unresectable stage iii non-small-cell lung cancer: a dosimetric study.
Nichols RC; Huh SN; Henderson RH; Mendenhall NP; Flampouri S; Li Z; D'Agostino HJ; Cury JD; Pham DC; Hoppe BS
Clin Lung Cancer; 2011 Jul; 12(4):252-7. PubMed ID: 21726825
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes of stereotactic radiotherapy for stage I non-small cell lung cancer using a novel irradiation technique: patient self-controlled breath-hold and beam switching using a combination of linear accelerator and CT scanner.
Onishi H; Kuriyama K; Komiyama T; Tanaka S; Sano N; Marino K; Ikenaga S; Araki T; Uematsu M
Lung Cancer; 2004 Jul; 45(1):45-55. PubMed ID: 15196734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
